Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct;9(10):4039-4045.
doi: 10.21037/jtd.2017.08.142.

Percutaneous thermal ablation for stage IA non-small cell lung cancer: long-term follow-up

Chaitan K Narsule  1 , Praveen Sridhar  1 , Divya Nair  1 , Avneesh Gupta  2 , Roy G Oommen  3 , Michael I Ebright  4 , Virginia R Litle  1 , Hiran C Fernando  5
Affiliations

Percutaneous thermal ablation for stage IA non-small cell lung cancer: long-term follow-up

Chaitan K Narsule et al. J Thorac Dis. 2017 Oct.

Abstract

Background: Surgical resection is the most effective curative therapy for non-small cell lung cancer (NSCLC). However, many patients are unable to tolerate resection secondary to poor reserve or comorbid disease. Radiofrequency ablation (RFA) and microwave ablation (MWA) are methods of percutaneous thermal ablation that can be used to treat medically inoperable patients with NSCLC. We present long-term outcomes following thermal ablation of stage IA NSCLC from a single center.

Methods: Patients with stage IA NSCLC and factors precluding resection who underwent RFA or MWA from July 2005 to September 2009 were studied. CT and PET-CT scans were performed at 3 and 6 month intervals, respectively, for first 24 months of follow-up. Factors associated with local progression (LP) and overall survival (OS) were analyzed.

Results: Twenty-one patients underwent 21 RFA and 4 MWA for a total of 25 ablations. Fifteen patients had T1a and six patients had T1b tumors. Mean follow-up was 42 months, median survival was 39 months, and OS at three years was 52%. There was no significant difference in median survival between T1a nodules and T1b nodules (36 vs. 39 months, P=0.29) or for RFA and MWA (36 vs. 50 months, P=0.80). Ten patients had LP (47.6%), at a median time of 35 months. There was no significant difference in LP between T1a and T1b tumors (22 vs. 35 months, P=0.94) or RFA and MWA (35 vs. 17 months, P=0.18). Median OS with LP was 32 months compared to 39 months without LP (P=0.68). Three patients underwent repeat ablations. Mean time to LP following repeat ablation was 14.75 months. One patient had two repeat ablations and was disease free at 40-month follow-up.

Conclusions: Thermal ablation effectively treated or controlled stage IA NSCLC in medically inoperable patients. Three-year OS exceeded 50%, and LP did not affect OS. Therefore, thermal ablation is a viable option for medically inoperable patients with early stage NSCLC.

Keywords: Lung cancer; microwave ablation (MWA); radiofrequency ablation (RFA); stage IA non-small cell lung cancer (NSCLC); thermal ablation.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Overall survival.
See this image and copyright information in PMC

References

    1. American Cancer Society (2014). Cancer Facts and Figures 2014. Available online: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/.... Last accessed 08/02/2014
    1. Cancer Stat Facts: Lung and Bronchus Cancer. Surveillance, Epidemiology, and End Results Program. National Cancer Institute. Available online: https://seer.cancer.gov/statfacts/html/lungb.html
    1. Khullar OV, Liu Y, Gillespie T, et al. Survival after sublobar resection versus lobectomy for clinical stage IA lung cancer. An analysis from the National Cancer Data Base. J Thorac Oncol 2015;10:1625-33. 10.1097/JTO.0000000000000664 - DOI - PMC - PubMed
    1. Higuchi M, Yaginuma H, Yonechi A, et al. Long-term outcomes after video-assisted thoracic surgery (VATS) lobectomy versus lobectomy via open thoracotomy for clinical stage IA non-small cell lung cancer. J Cardiothorac Surg 2014;9:88. 10.1186/1749-8090-9-88 - DOI - PMC - PubMed
    1. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-6. 10.1001/jama.2010.261 - DOI - PMC - PubMed

LinkOut - more resources